logo
Select company
Select metric
69.98%EBIT Margin
VS
Market
98
Sector
99
Industry
99
History
100
$ 1.23Close
$ 0.47 - $ 4.22 52-Week Range
Ticker Information

Ticker

NBY

Company Name

NOVABAY PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NOVABAY PHARMACEUTICALS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NBY - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ 3.32M69.98%$ 4.75M
3/31/2025$ 3.66M51.2%$ 7.15M
12/31/2024$ -7.22M-73.85%$ 9.78M
9/30/2024$ -10.12M-90.36%$ 11.2M
6/30/2024$ -10.66M-88.7%$ 12.02M
3/31/2024$ -11.12M-78.09%$ 14.23M
12/31/2023$ -9.64M-65.46%$ 14.73M
9/30/2023$ -13.74M-93.83%$ 14.64M
6/30/2023$ -12.12M-79.7%$ 15.2M
3/31/2023$ -12.24M-89.72%$ 13.64M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NOVABAY PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT % stands at -122.74%.
  • Over the past 5 years, NOVABAY PHARMACEUTICALS INC's average EBIT % has been -67.14%.
  • The median EBIT % for NOVABAY PHARMACEUTICALS INC during this period was -78.9%
  • NOVABAY PHARMACEUTICALS INC reached its highest EBIT % over the past 5 years at 69.98%.
  • The lowest EBIT % recorded by NOVABAY PHARMACEUTICALS INC in the same timeframe -122.74%

NOVABAY PHARMACEUTICALS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
INM : INMED PHARMACEUTICALS INC -157.62%XBIO : XENETIC BIOSCIENCES INC -126.03%CNSP : CNS PHARMACEUTICALS INC -ENVB : ENVERIC BIOSCIENCES INC -CPHI : CHINA PHARMA HOLDINGS INC -80.46%GRI : GRI BIO INC -AZTR : AZITRA INC -ONCO : ONCONETIX INC -3321.76%SPRB : SPRUCE BIOSCIENCES INC -3549.11%REVB : REVELATION BIOSCIENCES INC -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for NOVABAY PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -11.97M ] / Revenues [ $ 9.75M ]
(=) EBIT % [ -122.74% ]

NBY - EBIT Margin, Last 5 years

-122.74%

Minimum

Sep 30, 2020

69.98%

Maximum

Jun 30, 2025

-67.14%

Average

-78.9%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%